Influence of type 1 diabetes on basal and agonist-induced permeability of the blood–brain barrier

William G. Mayhan, Jasmine P. Scott, Denise M. Arrick

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Type 1 diabetes mellitus (T1D) impairs endothelial nitric oxide synthase (eNOS)-dependent responses of cerebral arterioles. However, the influence of T1D on another critical aspect of endothelial cell function in the cerebral microcirculation, i.e., regulation of permeability of the blood–brain barrier (BBB), remains largely unknown. Our goal was to examine basal and agonistinduced changes in permeability of the BBB in nondiabetic and type 1 diabetic (streptozotocin; 50 mg/kg IP) rats. On the day of the experiment (2–3 months after streptozotocin), a craniotomy was made over the parietal cortex in nondiabetic and diabetic rats. We measured the permeability of the BBB (FITCdextran- 10K) under basal conditions and during application of histamine. We also measured diameter of cerebral arterioles in response to histamine in the absence and presence of NG-monomethyl-L-arginine (L-NMMA). We found that basal permeability of the BBB was elevated in T1D and application of histamine did not produce a further increase in permeability. In contrast, basal permeability of the BBB was minimal in nondiabetics and histamine produced an increase in permeability. In addition, histamine-induced arteriolar dilation was less in diabetics than in nondiabetics, and vasodilation to histamine was inhibited by L-NMMA. Our findings suggest that T1D-induced endothelial dysfunction leads to an increase in basal permeability of the BBB, but decreases the ability of the endothelium of the BBB to respond to an important inflammatory mediator. Thus, T1D impairs two critical aspects of endothelial cell function in the cerebral microcirculation, i.e., basal and agonist- induced changes in permeability of the BBB and arteriolar dilation.

Original languageEnglish (US)
Article numbere12653
JournalPhysiological Reports
Volume3
Issue number12
DOIs
StatePublished - Jan 1 2015

Fingerprint

Type 1 Diabetes Mellitus
Permeability
Histamine
omega-N-Methylarginine
Arterioles
Microcirculation
Streptozocin
Dilatation
Endothelial Cells
Parietal Lobe
Nitric Oxide Synthase Type III
Craniotomy
Vasodilation
Endothelium

Keywords

  • Arterioles
  • Endothelium
  • Histamine
  • L-NMMA
  • Nitric oxide
  • Venules

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Influence of type 1 diabetes on basal and agonist-induced permeability of the blood–brain barrier. / Mayhan, William G.; Scott, Jasmine P.; Arrick, Denise M.

In: Physiological Reports, Vol. 3, No. 12, e12653, 01.01.2015.

Research output: Contribution to journalArticle

@article{8ce98eb12efd46f18bf5fda314313892,
title = "Influence of type 1 diabetes on basal and agonist-induced permeability of the blood–brain barrier",
abstract = "Type 1 diabetes mellitus (T1D) impairs endothelial nitric oxide synthase (eNOS)-dependent responses of cerebral arterioles. However, the influence of T1D on another critical aspect of endothelial cell function in the cerebral microcirculation, i.e., regulation of permeability of the blood–brain barrier (BBB), remains largely unknown. Our goal was to examine basal and agonistinduced changes in permeability of the BBB in nondiabetic and type 1 diabetic (streptozotocin; 50 mg/kg IP) rats. On the day of the experiment (2–3 months after streptozotocin), a craniotomy was made over the parietal cortex in nondiabetic and diabetic rats. We measured the permeability of the BBB (FITCdextran- 10K) under basal conditions and during application of histamine. We also measured diameter of cerebral arterioles in response to histamine in the absence and presence of NG-monomethyl-L-arginine (L-NMMA). We found that basal permeability of the BBB was elevated in T1D and application of histamine did not produce a further increase in permeability. In contrast, basal permeability of the BBB was minimal in nondiabetics and histamine produced an increase in permeability. In addition, histamine-induced arteriolar dilation was less in diabetics than in nondiabetics, and vasodilation to histamine was inhibited by L-NMMA. Our findings suggest that T1D-induced endothelial dysfunction leads to an increase in basal permeability of the BBB, but decreases the ability of the endothelium of the BBB to respond to an important inflammatory mediator. Thus, T1D impairs two critical aspects of endothelial cell function in the cerebral microcirculation, i.e., basal and agonist- induced changes in permeability of the BBB and arteriolar dilation.",
keywords = "Arterioles, Endothelium, Histamine, L-NMMA, Nitric oxide, Venules",
author = "Mayhan, {William G.} and Scott, {Jasmine P.} and Arrick, {Denise M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.14814/phy2.12653",
language = "English (US)",
volume = "3",
journal = "Physiological Reports",
issn = "2051-817X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Influence of type 1 diabetes on basal and agonist-induced permeability of the blood–brain barrier

AU - Mayhan, William G.

AU - Scott, Jasmine P.

AU - Arrick, Denise M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Type 1 diabetes mellitus (T1D) impairs endothelial nitric oxide synthase (eNOS)-dependent responses of cerebral arterioles. However, the influence of T1D on another critical aspect of endothelial cell function in the cerebral microcirculation, i.e., regulation of permeability of the blood–brain barrier (BBB), remains largely unknown. Our goal was to examine basal and agonistinduced changes in permeability of the BBB in nondiabetic and type 1 diabetic (streptozotocin; 50 mg/kg IP) rats. On the day of the experiment (2–3 months after streptozotocin), a craniotomy was made over the parietal cortex in nondiabetic and diabetic rats. We measured the permeability of the BBB (FITCdextran- 10K) under basal conditions and during application of histamine. We also measured diameter of cerebral arterioles in response to histamine in the absence and presence of NG-monomethyl-L-arginine (L-NMMA). We found that basal permeability of the BBB was elevated in T1D and application of histamine did not produce a further increase in permeability. In contrast, basal permeability of the BBB was minimal in nondiabetics and histamine produced an increase in permeability. In addition, histamine-induced arteriolar dilation was less in diabetics than in nondiabetics, and vasodilation to histamine was inhibited by L-NMMA. Our findings suggest that T1D-induced endothelial dysfunction leads to an increase in basal permeability of the BBB, but decreases the ability of the endothelium of the BBB to respond to an important inflammatory mediator. Thus, T1D impairs two critical aspects of endothelial cell function in the cerebral microcirculation, i.e., basal and agonist- induced changes in permeability of the BBB and arteriolar dilation.

AB - Type 1 diabetes mellitus (T1D) impairs endothelial nitric oxide synthase (eNOS)-dependent responses of cerebral arterioles. However, the influence of T1D on another critical aspect of endothelial cell function in the cerebral microcirculation, i.e., regulation of permeability of the blood–brain barrier (BBB), remains largely unknown. Our goal was to examine basal and agonistinduced changes in permeability of the BBB in nondiabetic and type 1 diabetic (streptozotocin; 50 mg/kg IP) rats. On the day of the experiment (2–3 months after streptozotocin), a craniotomy was made over the parietal cortex in nondiabetic and diabetic rats. We measured the permeability of the BBB (FITCdextran- 10K) under basal conditions and during application of histamine. We also measured diameter of cerebral arterioles in response to histamine in the absence and presence of NG-monomethyl-L-arginine (L-NMMA). We found that basal permeability of the BBB was elevated in T1D and application of histamine did not produce a further increase in permeability. In contrast, basal permeability of the BBB was minimal in nondiabetics and histamine produced an increase in permeability. In addition, histamine-induced arteriolar dilation was less in diabetics than in nondiabetics, and vasodilation to histamine was inhibited by L-NMMA. Our findings suggest that T1D-induced endothelial dysfunction leads to an increase in basal permeability of the BBB, but decreases the ability of the endothelium of the BBB to respond to an important inflammatory mediator. Thus, T1D impairs two critical aspects of endothelial cell function in the cerebral microcirculation, i.e., basal and agonist- induced changes in permeability of the BBB and arteriolar dilation.

KW - Arterioles

KW - Endothelium

KW - Histamine

KW - L-NMMA

KW - Nitric oxide

KW - Venules

UR - http://www.scopus.com/inward/record.url?scp=85006040050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006040050&partnerID=8YFLogxK

U2 - 10.14814/phy2.12653

DO - 10.14814/phy2.12653

M3 - Article

C2 - 26660561

AN - SCOPUS:85006040050

VL - 3

JO - Physiological Reports

JF - Physiological Reports

SN - 2051-817X

IS - 12

M1 - e12653

ER -